Wells Fargo’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $195K | Sell |
12,214
-1,640
| -12% | -$26.2K | ﹤0.01% | 4402 |
|
|
2025
Q1 | $211K | Buy |
13,854
+305
| +2% | +$4.64K | ﹤0.01% | 4230 |
|
|
2024
Q4 | $275K | Buy |
13,549
+2,951
| +28% | +$59.8K | ﹤0.01% | 4112 |
|
|
2024
Q3 | $272K | Buy |
10,598
+455
| +4% | +$11.7K | ﹤0.01% | 3997 |
|
|
2024
Q2 | $130K | Buy |
10,143
+10,017
| +7,950% | +$129K | ﹤0.01% | 4426 |
|
|
2024
Q1 | $2.89K | Buy |
126
+43
| +52% | +$985 | ﹤0.01% | 5585 |
|
|
2023
Q4 | $2.17K | Buy |
83
+69
| +493% | +$1.81K | ﹤0.01% | 5652 |
|
|
2023
Q3 | $391 | Sell |
14
-2
| -13% | -$56 | ﹤0.01% | 6038 |
|
|
2023
Q2 | $471 | Sell |
16
-393
| -96% | -$11.6K | ﹤0.01% | 6192 |
|
|
2023
Q1 | $7.69K | Buy |
+409
| New | +$7.69K | ﹤0.01% | 5615 |
|
|
2022
Q4 | – | Sell |
-5
| Closed | – | – | 7374 |
|
|
2022
Q3 | $0 | Sell |
5
-15
| -75% | – | ﹤0.01% | 7040 |
|
|
2022
Q2 | $1K | Sell |
20
-54
| -73% | -$2.7K | ﹤0.01% | 6314 |
|
|
2022
Q1 | $7K | Sell |
74
-790
| -91% | -$74.7K | ﹤0.01% | 6044 |
|
|
2021
Q4 | $132K | Buy |
+864
| New | +$132K | ﹤0.01% | 5107 |
|